Discover · The Research Behind It
Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline — Pottie et al., Can Fam Physician 2018
Last checked
- Free
- Worldwide
- Research paper
- Reading
- Online
Never stop or reduce a prescribed medicine on your own: some medicines cause withdrawal effects or a relapse if they are stopped or cut down too quickly. Use these resources to plan it with your prescriber.
- Published in
- Canadian Family Physician, 2018
- Evidence
- Moderate
- Cost
- Free.
What is this paper about?
This deprescribing.org guideline recommends offering a slow taper to adults aged 65 or over who take benzodiazepines or Z-drugs for insomnia, whatever the duration of use (strong recommendation, low-quality evidence), and suggests the same for adults aged 18 to 64 who have used them for over four weeks (weak recommendation). Its review found tapering improved stopping rates over usual care without serious harms; it advises involving patients in the tapering plan.
Why is it in the directory?
Backs up deprescribing.org and the Canadian Deprescribing Network in chapter 06, the slow-tapering approach the Benzodiazepine Information Coalition promotes, and the CBT-I programmes and sleep books in chapters 10 and 11, as the guideline pairs tapering with behavioural sleep advice.
Is it free to read?
Evidence-based clinical practice guideline (GRADE) with a systematic review of benzodiazepine and Z-drug deprescribing trials for insomnia. Moderate evidence. Can Fam Physician 2018;64(5):339–351. Free full text in PubMed Central (PMC5951648).
About the paper
- Authors
- Pottie K, Thompson W, Davies S, et al.
- Published in
- Can Fam Physician 2018;64(5):339–351
- Kind of study
- Evidence-based clinical practice guideline (GRADE) with a systematic review of benzodiazepine and Z-drug deprescribing trials for insomnia
- Strength of evidence
- Moderate — good studies, but fewer of them or with some limits
- Free to read
- Free in PMC (© College of Family Physicians of Canada)
Good to know
- The evidence was rated low quality, and it covers insomnia only, not benzodiazepines taken for anxiety or other conditions.
Where it sits in the directory
Listed under “Coming Off Medication Safely — Tapering & Deprescribing” in chapter 17 of the directory, The Research Behind It, with 12 other listings in the same category.
Similar listings
Also in the directory, with why each one is here.
- Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis — Lynch et al., Addiction 2020
Also a free research paper available worldwide, also for clinicians, in the same category.
Pooled 8 randomised trials (2,071 patients) of brief primary-care interventions for people taking benzodiazepines or Z-drugs for three months or more, mostly letters…
- Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline — Bjerre et al., Can Fam Physician 2018
Also a free research paper available worldwide, also for clinicians, in the same category.
Guideline from the deprescribing.org team, built with GRADE methods, a Cochrane review of antipsychotic withdrawal trials in dementia and a systematic review for…
- Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis — Henssler et al., Lancet Psychiatry 2024
Also a free research paper available worldwide, also for clinicians, in the same category.
Pooled 79 studies (21,002 people) in which an antidepressant or placebo was stopped.
- Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults — NICE 2022
Also a free research paper available worldwide, also for clinicians, in the same category.
NICE's guideline on withdrawing opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants.
- The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 — Riemann et al., J Sleep Res 2023
Also a free research paper available worldwide, also for clinicians, listed under “Sleep” in the same chapter.
European insomnia experts updated the European insomnia guideline.
- Say Good Night to Insomnia: The Six-Week, Drug-Free Program Developed at Harvard Medical School — Gregg D. Jacobs PhD (book & audiobook; Conquering Insomnia online program)
A guide or book available worldwide, listed under “Sleep” in Self-Help Library.
The original self-help version of cognitive behavioural therapy for insomnia (CBT-I), the first-line treatment in every major guideline, as a six-week programme: sleep…
This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.